Latest news
Form 424B3 SOLIGENIX, INC. - StreetInsiderStreetInsider · Fri, 07 Aug 2026 20:09:05 GMTOncoZenge Extends the Payment Deadline for Remaining Subscription Proceeds - TradingViewTradingView · Fri, 07 Aug 2026 14:30:00 GMTKlinefelter Syndrome Market to Witness Significant Growth - openPR.comopenPR.com · Tue, 04 Aug 2026 17:58:46 GMTAcute Ocular Pain Market to Reach USD 1.1 Billion by 2034 at ~13.8% CAGR Across the 7MM | DelveInsight - openPR.comopenPR.com · Tue, 04 Aug 2026 17:56:54 GMTDiabetic Retinopathy Market to Witness Growth Across the 7MM by 2036 | DelveInsight - openPR.comopenPR.com · Mon, 03 Aug 2026 12:10:55 GMTTendinopathy Market to Witness Steady Growth Through 2036, - openPR.comopenPR.com · Mon, 03 Aug 2026 12:02:19 GMTOral Mucositis Market Set to Grow Through 2036 as OncoZenge Advances BupiZenge Toward Pivotal Phase III Trial - openPR.comopenPR.com · Thu, 30 Jul 2026 07:00:00 GMTLipodystrophy Market Set to Grow Through 2036 as Mibavademab Advances Into Phase III Development - openPR.comopenPR.com · Thu, 30 Jul 2026 06:06:45 GMT